UNC Lineberger News

Carolina cracks top 10 in federal R&D expenditures

UNC-Chapel Hill rose to ninth from 16th among leading private and public research universities for the level of federal funding ($545.99 million) devoted to research and development in all fields during fiscal 2010.

Carolina cracks top 10 in federal R&D expenditures - Read More…

UNC headlines American Cancer Society breakfast

UNC headlines American Cancer Society breakfast

UNC Head Basketball Coach Roy Williams and UNC Lineberger physician-scientist Kim Rathmell, MD, PhD, were featured speakers at the American Cancer Society’s Cancer Action Network breakfast, held August 24th in Research Triangle Park.

UNC headlines American Cancer Society breakfast - Read More…

Program offers outdoor adventures to cancer survivors, UNC faculty volunteer services

Kayaking and rock climbing aren’t usual clinical activities for UNC Lineberger medical oncologist Dr. Juneko Grilley-Olson and nurse practitioner Elizabeth Sherwood, but they were during the time that each volunteered for a First Descents camp week for young adult cancer survivors.

Program offers outdoor adventures to cancer survivors, UNC faculty volunteer services - Read More…

Study reveals new molecular target for melanoma treatment

Study reveals new molecular target for melanoma treatment

Chapel Hill, NC – A laboratory study led by UNC medical oncologist Stergios Moschos, MD, demonstrates how a new targeted drug, Elesclomol, blocks oxidative phosphorylation, which appears to play essential role in melanoma that has not been well-understood.

Study reveals new molecular target for melanoma treatment - Read More…

The V Foundation selects UNC team as 2012 translational grant recipients

The V Foundation selects UNC team as 2012 translational grant recipients

The V Foundation for Cancer Research, one of the nation’s leading cancer research foundations, has awarded a $600,000 grant to a UNC Lineberger team.

The V Foundation selects UNC team as 2012 translational grant recipients - Read More…

B Cell survival holds key to chronic graft vs. host disease

B Cell survival holds key to chronic graft vs. host disease

Chapel Hill, NC – Leukemia and lymphoma patients who receive life-saving stem cell or bone marrow transplants often experience chronic side effects that significantly decrease quality of life, can last a lifetime, and ultimately affect their long-term survival.

B Cell survival holds key to chronic graft vs. host disease - Read More…

Kathy DeClue: a selfless gift from a younger brother

A Randolph County woman with leukemia receives stem cells from her youngest brother in hopes of restoring her health and returning to work as a baker.

Kathy DeClue: a selfless gift from a younger brother - Read More…

Making the case for adjuvant chemotherapy for older patients with colon cancer

Making the case for adjuvant chemotherapy for older patients with colon cancer

Hy Muss, MD, and Debra Bynum, MD, co-authored an editorial in the July 20, 2012 issue of the Journal of Clinical Oncology.

Making the case for adjuvant chemotherapy for older patients with colon cancer - Read More…